The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Live Herpes Zoster Vaccine Market Research Report 2025
Synopsis
Live Herpes Zoster Vaccine refers to a vaccine used to prevent shingles. Shingles is a disease caused by the varicella-zoster virus, which usually reoccurs years after a chickenpox infection. This vaccine is attenuated, using a live virus strain that has been weakened, hence the name attenuated vaccine. Vaccination with the attenuated shingles vaccine can help prevent or reduce episodes of shingles and reduce the risk of complications. (Now all companies have achieved commercial production, except for SIBP CNBG, which is in the Phase II experimental stage.)
The global Live Herpes Zoster Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Live Herpes Zoster Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Live Herpes Zoster Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Live Herpes Zoster Vaccine include Merck, GSK, SK, Changchun BCHT Biotechnology, SIBP CNBG, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Live Herpes Zoster Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Live Herpes Zoster Vaccine.
The Live Herpes Zoster Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Live Herpes Zoster Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Live Herpes Zoster Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Merck
GSK
SK
Changchun BCHT Biotechnology
SIBP CNBG
Segment by Type
Single-dose Vaccination
Double-dose Vaccination
Segment by Application
Public Health Sector
Hospitals & clinics
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Live Herpes Zoster Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Live Herpes Zoster Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Live Herpes Zoster Vaccine refers to a vaccine used to prevent shingles. Shingles is a disease caused by the varicella-zoster virus, which usually reoccurs years after a chickenpox infection. This vaccine is attenuated, using a live virus strain that has been weakened, hence the name attenuated vaccine. Vaccination with the attenuated shingles vaccine can help prevent or reduce episodes of shingles and reduce the risk of complications. (Now all companies have achieved commercial production, except for SIBP CNBG, which is in the Phase II experimental stage.)
The global Live Herpes Zoster Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Live Herpes Zoster Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Live Herpes Zoster Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Live Herpes Zoster Vaccine include Merck, GSK, SK, Changchun BCHT Biotechnology, SIBP CNBG, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Live Herpes Zoster Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Live Herpes Zoster Vaccine.
The Live Herpes Zoster Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Live Herpes Zoster Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Live Herpes Zoster Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Merck
GSK
SK
Changchun BCHT Biotechnology
SIBP CNBG
Segment by Type
Single-dose Vaccination
Double-dose Vaccination
Segment by Application
Public Health Sector
Hospitals & clinics
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Live Herpes Zoster Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Live Herpes Zoster Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Live Herpes Zoster Vaccine Market Overview
1.1 Product Definition
1.2 Live Herpes Zoster Vaccine by Type
1.2.1 Global Live Herpes Zoster Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Single-dose Vaccination
1.2.3 Double-dose Vaccination
1.3 Live Herpes Zoster Vaccine by Application
1.3.1 Global Live Herpes Zoster Vaccine Market Value by Application (2024-2030)
1.3.2 Public Health Sector
1.3.3 Hospitals & clinics
1.3.4 Others
1.4 Global Live Herpes Zoster Vaccine Market Size Estimates and Forecasts
1.4.1 Global Live Herpes Zoster Vaccine Revenue 2019-2030
1.4.2 Global Live Herpes Zoster Vaccine Sales 2019-2030
1.4.3 Global Live Herpes Zoster Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Live Herpes Zoster Vaccine Market Competition by Manufacturers
2.1 Global Live Herpes Zoster Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Live Herpes Zoster Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Live Herpes Zoster Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Live Herpes Zoster Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Live Herpes Zoster Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Live Herpes Zoster Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Live Herpes Zoster Vaccine, Date of Enter into This Industry
2.8 Global Live Herpes Zoster Vaccine Market Competitive Situation and Trends
2.8.1 Global Live Herpes Zoster Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Live Herpes Zoster Vaccine Players Market Share by Revenue
2.8.3 Global Live Herpes Zoster Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Live Herpes Zoster Vaccine Market Scenario by Region
3.1 Global Live Herpes Zoster Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Live Herpes Zoster Vaccine Sales by Region: 2019-2030
3.2.1 Global Live Herpes Zoster Vaccine Sales by Region: 2019-2024
3.2.2 Global Live Herpes Zoster Vaccine Sales by Region: 2025-2030
3.3 Global Live Herpes Zoster Vaccine Revenue by Region: 2019-2030
3.3.1 Global Live Herpes Zoster Vaccine Revenue by Region: 2019-2024
3.3.2 Global Live Herpes Zoster Vaccine Revenue by Region: 2025-2030
3.4 North America Live Herpes Zoster Vaccine Market Facts & Figures by Country
3.4.1 North America Live Herpes Zoster Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Live Herpes Zoster Vaccine Sales by Country (2019-2030)
3.4.3 North America Live Herpes Zoster Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Live Herpes Zoster Vaccine Market Facts & Figures by Country
3.5.1 Europe Live Herpes Zoster Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Live Herpes Zoster Vaccine Sales by Country (2019-2030)
3.5.3 Europe Live Herpes Zoster Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Live Herpes Zoster Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Live Herpes Zoster Vaccine Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Live Herpes Zoster Vaccine Sales by Region (2019-2030)
3.6.3 Asia Pacific Live Herpes Zoster Vaccine Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Live Herpes Zoster Vaccine Market Facts & Figures by Country
3.7.1 Latin America Live Herpes Zoster Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Live Herpes Zoster Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Live Herpes Zoster Vaccine Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Live Herpes Zoster Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Live Herpes Zoster Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Live Herpes Zoster Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Live Herpes Zoster Vaccine Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Live Herpes Zoster Vaccine Sales by Type (2019-2030)
4.1.1 Global Live Herpes Zoster Vaccine Sales by Type (2019-2024)
4.1.2 Global Live Herpes Zoster Vaccine Sales by Type (2025-2030)
4.1.3 Global Live Herpes Zoster Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Live Herpes Zoster Vaccine Revenue by Type (2019-2030)
4.2.1 Global Live Herpes Zoster Vaccine Revenue by Type (2019-2024)
4.2.2 Global Live Herpes Zoster Vaccine Revenue by Type (2025-2030)
4.2.3 Global Live Herpes Zoster Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Live Herpes Zoster Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Live Herpes Zoster Vaccine Sales by Application (2019-2030)
5.1.1 Global Live Herpes Zoster Vaccine Sales by Application (2019-2024)
5.1.2 Global Live Herpes Zoster Vaccine Sales by Application (2025-2030)
5.1.3 Global Live Herpes Zoster Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Live Herpes Zoster Vaccine Revenue by Application (2019-2030)
5.2.1 Global Live Herpes Zoster Vaccine Revenue by Application (2019-2024)
5.2.2 Global Live Herpes Zoster Vaccine Revenue by Application (2025-2030)
5.2.3 Global Live Herpes Zoster Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Live Herpes Zoster Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Live Herpes Zoster Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Live Herpes Zoster Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Live Herpes Zoster Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Live Herpes Zoster Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 SK
6.3.1 SK Company Information
6.3.2 SK Description and Business Overview
6.3.3 SK Live Herpes Zoster Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 SK Live Herpes Zoster Vaccine Product Portfolio
6.3.5 SK Recent Developments/Updates
6.4 Changchun BCHT Biotechnology
6.4.1 Changchun BCHT Biotechnology Company Information
6.4.2 Changchun BCHT Biotechnology Description and Business Overview
6.4.3 Changchun BCHT Biotechnology Live Herpes Zoster Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Changchun BCHT Biotechnology Live Herpes Zoster Vaccine Product Portfolio
6.4.5 Changchun BCHT Biotechnology Recent Developments/Updates
6.5 SIBP CNBG
6.5.1 SIBP CNBG Company Information
6.5.2 SIBP CNBG Description and Business Overview
6.5.3 SIBP CNBG Live Herpes Zoster Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 SIBP CNBG Live Herpes Zoster Vaccine Product Portfolio
6.5.5 SIBP CNBG Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Live Herpes Zoster Vaccine Industry Chain Analysis
7.2 Live Herpes Zoster Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Live Herpes Zoster Vaccine Production Mode & Process
7.4 Live Herpes Zoster Vaccine Sales and Marketing
7.4.1 Live Herpes Zoster Vaccine Sales Channels
7.4.2 Live Herpes Zoster Vaccine Distributors
7.5 Live Herpes Zoster Vaccine Customers
8 Live Herpes Zoster Vaccine Market Dynamics
8.1 Live Herpes Zoster Vaccine Industry Trends
8.2 Live Herpes Zoster Vaccine Market Drivers
8.3 Live Herpes Zoster Vaccine Market Challenges
8.4 Live Herpes Zoster Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Live Herpes Zoster Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Live Herpes Zoster Vaccine Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Live Herpes Zoster Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Live Herpes Zoster Vaccine Sales (K Dose) of Key Manufacturers (2019-2024)
Table 5. Global Live Herpes Zoster Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Live Herpes Zoster Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Live Herpes Zoster Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Live Herpes Zoster Vaccine Average Price (US$/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Live Herpes Zoster Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Live Herpes Zoster Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Live Herpes Zoster Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Live Herpes Zoster Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Live Herpes Zoster Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Herpes Zoster Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Live Herpes Zoster Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Live Herpes Zoster Vaccine Sales by Region (2019-2024) & (K Dose)
Table 18. Global Live Herpes Zoster Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Live Herpes Zoster Vaccine Sales by Region (2025-2030) & (K Dose)
Table 20. Global Live Herpes Zoster Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Live Herpes Zoster Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Live Herpes Zoster Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Live Herpes Zoster Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Live Herpes Zoster Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Live Herpes Zoster Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Live Herpes Zoster Vaccine Sales by Country (2019-2024) & (K Dose)
Table 27. North America Live Herpes Zoster Vaccine Sales by Country (2025-2030) & (K Dose)
Table 28. North America Live Herpes Zoster Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Live Herpes Zoster Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Live Herpes Zoster Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Live Herpes Zoster Vaccine Sales by Country (2019-2024) & (K Dose)
Table 32. Europe Live Herpes Zoster Vaccine Sales by Country (2025-2030) & (K Dose)
Table 33. Europe Live Herpes Zoster Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Live Herpes Zoster Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Live Herpes Zoster Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Live Herpes Zoster Vaccine Sales by Region (2019-2024) & (K Dose)
Table 37. Asia Pacific Live Herpes Zoster Vaccine Sales by Region (2025-2030) & (K Dose)
Table 38. Asia Pacific Live Herpes Zoster Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Live Herpes Zoster Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Live Herpes Zoster Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Live Herpes Zoster Vaccine Sales by Country (2019-2024) & (K Dose)
Table 42. Latin America Live Herpes Zoster Vaccine Sales by Country (2025-2030) & (K Dose)
Table 43. Latin America Live Herpes Zoster Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Live Herpes Zoster Vaccine Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Live Herpes Zoster Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Live Herpes Zoster Vaccine Sales by Country (2019-2024) & (K Dose)
Table 47. Middle East and Africa Live Herpes Zoster Vaccine Sales by Country (2025-2030) & (K Dose)
Table 48. Middle East and Africa Live Herpes Zoster Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Live Herpes Zoster Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Live Herpes Zoster Vaccine Sales (K Dose) by Type (2019-2024)
Table 51. Global Live Herpes Zoster Vaccine Sales (K Dose) by Type (2025-2030)
Table 52. Global Live Herpes Zoster Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Live Herpes Zoster Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Live Herpes Zoster Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Live Herpes Zoster Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Live Herpes Zoster Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Live Herpes Zoster Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Live Herpes Zoster Vaccine Price (US$/Dose) by Type (2019-2024)
Table 59. Global Live Herpes Zoster Vaccine Price (US$/Dose) by Type (2025-2030)
Table 60. Global Live Herpes Zoster Vaccine Sales (K Dose) by Application (2019-2024)
Table 61. Global Live Herpes Zoster Vaccine Sales (K Dose) by Application (2025-2030)
Table 62. Global Live Herpes Zoster Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Live Herpes Zoster Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Live Herpes Zoster Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Live Herpes Zoster Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Live Herpes Zoster Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Live Herpes Zoster Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Live Herpes Zoster Vaccine Price (US$/Dose) by Application (2019-2024)
Table 69. Global Live Herpes Zoster Vaccine Price (US$/Dose) by Application (2025-2030)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck Live Herpes Zoster Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 73. Merck Live Herpes Zoster Vaccine Product
Table 74. Merck Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK Live Herpes Zoster Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 78. GSK Live Herpes Zoster Vaccine Product
Table 79. GSK Recent Developments/Updates
Table 80. SK Company Information
Table 81. SK Description and Business Overview
Table 82. SK Live Herpes Zoster Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 83. SK Live Herpes Zoster Vaccine Product
Table 84. SK Recent Developments/Updates
Table 85. Changchun BCHT Biotechnology Company Information
Table 86. Changchun BCHT Biotechnology Description and Business Overview
Table 87. Changchun BCHT Biotechnology Live Herpes Zoster Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 88. Changchun BCHT Biotechnology Live Herpes Zoster Vaccine Product
Table 89. Changchun BCHT Biotechnology Recent Developments/Updates
Table 90. SIBP CNBG Company Information
Table 91. SIBP CNBG Description and Business Overview
Table 92. SIBP CNBG Live Herpes Zoster Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 93. SIBP CNBG Live Herpes Zoster Vaccine Product
Table 94. SIBP CNBG Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Live Herpes Zoster Vaccine Distributors List
Table 98. Live Herpes Zoster Vaccine Customers List
Table 99. Live Herpes Zoster Vaccine Market Trends
Table 100. Live Herpes Zoster Vaccine Market Drivers
Table 101. Live Herpes Zoster Vaccine Market Challenges
Table 102. Live Herpes Zoster Vaccine Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Product Picture of Live Herpes Zoster Vaccine
Figure 2. Global Live Herpes Zoster Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Live Herpes Zoster Vaccine Market Share by Type: 2023 & 2030
Figure 4. Single-dose Vaccination Product Picture
Figure 5. Double-dose Vaccination Product Picture
Figure 6. Global Live Herpes Zoster Vaccine Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Live Herpes Zoster Vaccine Market Share by Application: 2023 & 2030
Figure 8. Public Health Sector
Figure 9. Hospitals & clinics
Figure 10. Others
Figure 11. Global Live Herpes Zoster Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Live Herpes Zoster Vaccine Market Size (2019-2030) & (US$ Million)
Figure 13. Global Live Herpes Zoster Vaccine Sales (2019-2030) & (K Dose)
Figure 14. Global Live Herpes Zoster Vaccine Average Price (US$/Dose) & (2019-2030)
Figure 15. Live Herpes Zoster Vaccine Report Years Considered
Figure 16. Live Herpes Zoster Vaccine Sales Share by Manufacturers in 2023
Figure 17. Global Live Herpes Zoster Vaccine Revenue Share by Manufacturers in 2023
Figure 18. Global 5 and 10 Largest Live Herpes Zoster Vaccine Players: Market Share by Revenue in Live Herpes Zoster Vaccine in 2023
Figure 19. Live Herpes Zoster Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Live Herpes Zoster Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Live Herpes Zoster Vaccine Sales Market Share by Country (2019-2030)
Figure 22. North America Live Herpes Zoster Vaccine Revenue Market Share by Country (2019-2030)
Figure 23. United States Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Live Herpes Zoster Vaccine Sales Market Share by Country (2019-2030)
Figure 26. Europe Live Herpes Zoster Vaccine Revenue Market Share by Country (2019-2030)
Figure 27. Germany Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Live Herpes Zoster Vaccine Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Live Herpes Zoster Vaccine Revenue Market Share by Region (2019-2030)
Figure 34. China Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Live Herpes Zoster Vaccine Sales Market Share by Country (2019-2030)
Figure 42. Mexico Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East and Africa Live Herpes Zoster Vaccine Sales Market Share by Country (2019-2030)
Figure 47. Middle East and Africa Live Herpes Zoster Vaccine Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Live Herpes Zoster Vaccine by Type (2019-2030)
Figure 52. Global Revenue Market Share of Live Herpes Zoster Vaccine by Type (2019-2030)
Figure 53. Global Live Herpes Zoster Vaccine Price (US$/Dose) by Type (2019-2030)
Figure 54. Global Sales Market Share of Live Herpes Zoster Vaccine by Application (2019-2030)
Figure 55. Global Revenue Market Share of Live Herpes Zoster Vaccine by Application (2019-2030)
Figure 56. Global Live Herpes Zoster Vaccine Price (US$/Dose) by Application (2019-2030)
Figure 57. Live Herpes Zoster Vaccine Value Chain
Figure 58. Live Herpes Zoster Vaccine Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
